Advaxis, Inc.
Advaxis Added to Stonegate's Equity Research Universe
Published in Oncology Business Week, November 1st, 2009
Stonegate Securities has initiated research coverage on Advaxis, Inc., (OTCBB: ADXS) the live, attenuated Listeria monocytogenes (Lm) vaccine company, last week. For more information on the research report, please contact Marco Rodriguez, CFA of Stonegate Securities at marco@stonegateinc.com and/or your local investment professional. About the Company Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis' scientific advisory board. Advaxis is developing attenuated live Lm vaccines that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Access to Integrated Cancer Care AICC
Congressional Letter Highlights Increased Racial Health Disparities and Barriers to Cancer Care in Proposed CMS Policy - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences to Present at 8th Annual BIO Investor Forum - Advaxis, Inc.
Advaxis Chief Science Officer to Present Benefits of Using Live Listeria as a Vaccine - Affymetrix, Inc.
Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study - Aging
Kaiser Permanente, UCSF Awarded $25 Million From NIH to Build Groundbreaking Resource for Genetic Epidemiology Research - Alpha Systems
Alpha Systems to Provide Electronic Document Management to Virtua - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
